Conversa, a Portland, Ore.-based telehealth startup, has raised another $8 million as part of an expanded Series B round.
The company announced a $12 million round in June co-led by Builders VC and Northwell Ventures. Total funding to date is now $34 million.
Founded in 2014, Conversa sells various platforms that allow care teams to communicate with patients virtually. The platforms are each tailored to different conditions, including asthma, congestive heart failure, diabetes, joint replacement, and more.
Conversa last year released a suite of COVID-19 virtual care programs being used by health systems across the U.S. The company is also working with employers who need help checking on the health of employees.
Conversa said it had “sixfold growth” of its platform last year as virtual healthcare adoption accelerates amid the pandemic.